| Jeffrey Pinco, MD | |
|
5755 Cedar Ln Dept Of, Columbia, MD 21044 | |
| (410) 740-7861 | |
| Not Available |
| Full Name | Jeffrey Pinco |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 26 Years |
| Location | 5755 Cedar Ln Dept Of, Columbia, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336148873 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Howard County General Hospital | Columbia, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
On Wednesday, October 21 at 2:00 p.m. in Rayburn House Office Building, Room 2172, Chairman Delahunt (D-MA) of the House Foreign Affairs Subcommittee on International Organizations, Human Rights and Oversight will hold a hearing titled International Violence Against Women: Stories and Solutions.
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
Dark chocolate has already been hailed for its positive effects on cardiovascular health - and now a study undertaken at London's Kingston University has found the tasty treat could help give sports enthusiasts an extra edge in their fitness training.
An approach to converting the data from MRI (magnetic resonance imaging) machines, mammograms and other medical equipment gives doctors a much clearer picture of your insides and a chance to detect disease and other problems earlier, according to research published in the International Journal of Biomedical Engineering and Technology.
› Verified 4 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
On Wednesday, October 21 at 2:00 p.m. in Rayburn House Office Building, Room 2172, Chairman Delahunt (D-MA) of the House Foreign Affairs Subcommittee on International Organizations, Human Rights and Oversight will hold a hearing titled International Violence Against Women: Stories and Solutions.
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
Dark chocolate has already been hailed for its positive effects on cardiovascular health - and now a study undertaken at London's Kingston University has found the tasty treat could help give sports enthusiasts an extra edge in their fitness training.
An approach to converting the data from MRI (magnetic resonance imaging) machines, mammograms and other medical equipment gives doctors a much clearer picture of your insides and a chance to detect disease and other problems earlier, according to research published in the International Journal of Biomedical Engineering and Technology.
› Verified 4 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000347 |
News Archive
On Wednesday, October 21 at 2:00 p.m. in Rayburn House Office Building, Room 2172, Chairman Delahunt (D-MA) of the House Foreign Affairs Subcommittee on International Organizations, Human Rights and Oversight will hold a hearing titled International Violence Against Women: Stories and Solutions.
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
Dark chocolate has already been hailed for its positive effects on cardiovascular health - and now a study undertaken at London's Kingston University has found the tasty treat could help give sports enthusiasts an extra edge in their fitness training.
An approach to converting the data from MRI (magnetic resonance imaging) machines, mammograms and other medical equipment gives doctors a much clearer picture of your insides and a chance to detect disease and other problems earlier, according to research published in the International Journal of Biomedical Engineering and Technology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Pinco, MD 3911 White Rose Way, Ellicott City, MD 21042-5801 Ph: (443) 741-0798 | Jeffrey Pinco, MD 5755 Cedar Ln Dept Of, Columbia, MD 21044 Ph: (410) 740-7861 |
News Archive
On Wednesday, October 21 at 2:00 p.m. in Rayburn House Office Building, Room 2172, Chairman Delahunt (D-MA) of the House Foreign Affairs Subcommittee on International Organizations, Human Rights and Oversight will hold a hearing titled International Violence Against Women: Stories and Solutions.
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
Dark chocolate has already been hailed for its positive effects on cardiovascular health - and now a study undertaken at London's Kingston University has found the tasty treat could help give sports enthusiasts an extra edge in their fitness training.
An approach to converting the data from MRI (magnetic resonance imaging) machines, mammograms and other medical equipment gives doctors a much clearer picture of your insides and a chance to detect disease and other problems earlier, according to research published in the International Journal of Biomedical Engineering and Technology.
› Verified 4 days ago
Rennae Anderson, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-940-7890 | |
Dr. Richard Charles Marsella, M.D.,PH.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5450 Knoll North Dr, Columbia, MD 21045 Phone: 443-618-6596 | |
Dr. Henry Harrison Bell Jr., M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7852 | |
Anita Godra, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 10320 Swift Stream Pl, #405, Columbia, MD 21044 Phone: 410-423-9481 | |
Dr. Stephanie Michelle Richards, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7861 | |
Lola Hoover, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7890 |